KLRC2 and cancer: ,29 In addition, we gathered spatial transcriptomics data from five different patients for breast, prostate, and ovarian cancer to understand how cell-cell interactions differ between NKG2A+ and NKG2C+ CD8+ T cells across cancer types.64